TL;DR: On sale for a one-time payment of $99.99, Microsoft Visio Professional 2024 delivers powerful, intuitive tools to turn ideas into organized, visual plans. Sometimes, explaining complex ...

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel ...

DUBLIN, November 13, 2024--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON ...

Icon PLC (ICLR) came out with quarterly earnings of $3.35 per share, missing the Zacks Consensus Estimate of $3.85 per share. This compares to earnings of $3.30 per share a year ago. These figures ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc ...

ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announced that Dr. Steve Cutler, CEO of ICON plc and Mr. Nigel Clerkin, CFO of ICON plc will ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organization powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the TD Cowen ...

Net business wins in the quarter of $2,328 million. Reflects a net book to bill in the quarter of 1.15, and a trailing twelve month net book to bill of 1.21. Closing backlog of $24.3 billion, an ...

Icon (ICLR) has released an update. Icon plc’s subsidiaries are providing guarantees for its Senior Secured Notes, which are due in 2027, 2029, and 2034, with interest rates ranging from 5.809% ...

On Thursday, Baird adjusted the rating for ICON plc (NASDAQ:ICLR) stock, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The ...